A role for ephrins-A2, -A3, & -A5 in excitatory synaptic development and function

肝配蛋白-A2、-A3 的作用,

基本信息

  • 批准号:
    8537222
  • 负责人:
  • 金额:
    $ 2.98万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-08-01 至 2015-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Complex thoughts and movements require the integration of topographically organized cortical information about sensory, motor, and motivational states. These integrated networks involve corticostriatal synapses on dendritic spines of medium spiny projection neurons (MSNs), which are organized into unique compartments within the striatum. Epigenetic and genetic factors that alter the expression of molecules regulating the normal development of striatal neuronal compartments, corticostriatal afferent organization, or synaptic physiology could be involved in the etiology of the neuropsychiatric disorders associated with the striatum. Thus, my proposal aims are to identify a role for members of one molecular family of cell-surface signaling molecules, the A-class ephrins, in the proper development of striatal circuitry. Eph/ephrins are compelling candidate molecules that could participate in developmental events necessary to regulate the proper formation of striatal compartments and corticostriatal synaptogenesis due to their ability to regulate neuronal migration, axonal pathway topography and dendritic morphology, as well as modulate synaptic function via glutamate receptor trafficking. Mice with genetic deletions of ephrins-A2, -A3, and -A5 have disorganized striatal sub compartments and display differences in locomotor activity levels, repetitive facial grooming, and perseverance of inappropriate motor strategies during learning. These observations suggest that certain A- ephrins could differentially affect anatomical and physiological features essential for normal behaviors associated with corticostriatal function. It is currently unknown whether changes in the relative expression of ephrin-A2, -A3, and/or -A5 affect synaptic development or neurotransmission at corticostriatal synapses. Therefore, this research will include electrophysiology studies to examine changes in glutamate receptor trafficking and stereological studies of morphology to measure changes in dendrites of medium spiny neurons (MSNs), the main projection neurons in the striatum. Two subtypes of MSNs are distinguished by dopamine receptor D1 or D2 expression and these form the "direct" and "indirect" basal ganglia pathways, respectively. As many neuropsychiatric disorders linked to striatal dysfunction are thought to involve a functional imbalance between these two pathways, it is of particular interest to understand the effect that changes in the relative proportion of A-ephrins might have on excitatory physiology in these two populations of MSNs. This proposal entails use of unique transgenic mice expressing fluorescent marker proteins in each MSN subtype in combination with genetic deletions of ephrins-A2, -A3, and/or -A5. This model permits assessment of glutamate receptor activity and dendritic morphology in D1+ vs. D2+ MSNs. The guiding hypothesis is that changes in glutamatergic synaptic transmission and dendritic morphology will occur differentially in D1+ versus D2+ MSNs of mice with specific deletions of ephrins-A2/3/5. These studies will thus evaluate genetic factors that could contribute at multiple levels to the etiology of developmental neuropsychiatric disorders.
描述(由申请人提供):复杂的思想和运动需要整合有关感觉、运动和动机状态的地形组织的皮质信息。这些综合网络包括中棘投射神经元树突棘上的皮质纹状体突触,这些突触在纹状体中被组织成独特的隔室。表观遗传和遗传因素改变调节纹状体神经元室、皮质纹状体传入组织或突触生理正常发育的分子表达,可能与纹状体相关的神经精神疾病的病因有关。因此,我的建议的目的是确定细胞表面信号分子的一个分子家族的成员,a类ephrins,在纹状体电路的适当发展中的作用。由于Eph/ephrin能够调节神经元迁移、轴突通路地形和树突形态,以及通过谷氨酸受体运输调节突触功能,因此它是一种引人注目的候选分子,可能参与调节纹状体室的适当形成和皮质纹状体突触发生所必需的发育事件。肾上腺素- a2、-A3和-A5基因缺失的小鼠纹状体亚室紊乱,在运动活动水平、重复面部修饰和学习过程中不适当运动策略的坚持方面表现出差异。这些观察结果表明,某些A- ephrin可能不同地影响与皮质纹状体功能相关的正常行为所必需的解剖和生理特征。目前尚不清楚ephrin-A2、-A3和/或-A5的相对表达变化是否影响皮质纹状体突触的突触发育或神经传递。因此,本研究将包括检测谷氨酸受体转运变化的电生理学研究和测量纹状体主要投射神经元中棘神经元(MSNs)树突变化的形态学立体学研究。两种msn亚型通过多巴胺受体D1或D2的表达来区分,它们分别形成“直接”和“间接”基底神经节通路。由于许多与纹状体功能障碍相关的神经精神疾病被认为涉及这两种途径之间的功能失衡,因此了解a -ephrin相对比例的变化可能对这两种msn人群的兴奋生理产生的影响是特别有趣的。该建议需要使用独特的转基因小鼠,在每种MSN亚型中表达荧光标记蛋白,并结合ephrin - a2, -A3和/或-A5的遗传缺失。该模型允许评估D1+与D2+ msn中谷氨酸受体活性和树突形态。指导性假设是,特异性缺失ephrin - a2 /3/5的小鼠D1+和D2+ msn中,谷氨酸能突触传递和树突形态的变化会发生差异。因此,这些研究将评估可能在多个层面上对发育性神经精神障碍病因做出贡献的遗传因素。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Rachel Wurzman其他文献

Rachel Wurzman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Rachel Wurzman', 18)}}的其他基金

A role for ephrins-A2, -A3, & -A5 in excitatory synaptic development and function
肝配蛋白-A2、-A3 的作用,
  • 批准号:
    8686084
  • 财政年份:
    2012
  • 资助金额:
    $ 2.98万
  • 项目类别:
A role for ephrins-A2, -A3, & -A5 in excitatory synaptic development and function
肝配蛋白-A2、-A3 的作用,
  • 批准号:
    8401070
  • 财政年份:
    2012
  • 资助金额:
    $ 2.98万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.98万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 2.98万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.98万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.98万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.98万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.98万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.98万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 2.98万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 2.98万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 2.98万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了